首页> 美国卫生研究院文献>Saudi Journal of Medicine Medical Sciences >Sudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemia
【2h】

Sudden Visual Loss as an Initial Manifestation of Chronic Myeloid Leukemia

机译:突然的视力减退是慢性粒细胞白血病的最初表现

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by anemia, granulocytosis and granulocytic immaturity, basophilia, thrombocytosis and splenomegaly. It is associated with a reciprocal chromosomal translocation t (q34; q11), resulting in a breakpoint cluster region–Abelson fusion gene (Philadelphia chromosome). Ophthalmic manifestations as the first and the only presentation of CML in patients are very rare. Ocular lesions in CML patients are frequently asymptomatic, and thus all patients should undergo an eye evaluation at the initial diagnosis. Here, we report a previously healthy 36-year-old Saudi male who initially presented with progressive loss of vision. On examination, he was found to have a bilateral retinal hemorrhage. The investigations revealed findings consistent with CML. The patient was treated with tyrosine kinase inhibitors, and he had complete remission, including full recovery of his vision.
机译:慢性粒细胞性白血病(CML)是一种多能干细胞疾病,其特征在于贫血,粒细胞增多和粒细胞不成熟,嗜碱性粒细胞增多,血小板增多和脾肿大。它与相互的染色体易位t(q34; q11)相关,从而导致一个断点簇区域– Abelson融合基因(费城染色体)。在患者中,眼病是CML的首例也是唯一的表现。 CML患者的眼部病变通常无症状,因此所有患者在初诊时都应进行眼部评估。在这里,我们报告了先前健康的36岁沙特男性,最初表现为进行性视力丧失。经检查,发现他患有双侧视网膜出血。调查显示发现与CML一致。该患者接受酪氨酸激酶抑制剂治疗,病情完全缓解,包括视力完全恢复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号